Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Omeros Corporation - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
OMER
Nasdaq
2830
www.omeros.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Omeros Corporation
Bears are Losing Control Over Omeros (OMER), Here's Why It's a 'Buy' Now
- Jun 4th, 2026 7:55 am
Omeros (OMER) Q1 2026 Earnings Transcript
- May 14th, 2026 9:14 am
Omeros Corporation Q1 2026 Earnings Call Summary
- May 14th, 2026 6:30 am
Omeros Corp (OMER) Q1 2026 Earnings Call Highlights: Strong YARTEMLEA Launch and Strategic ...
- May 13th, 2026 11:02 pm
Omeros Q1 Earnings Call Highlights
- May 13th, 2026 10:12 pm
Omeros Corporation Reports First Quarter 2026 Financial Results
- May 13th, 2026 2:02 pm
Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026
- May 11th, 2026 2:02 pm
Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway
- Apr 28th, 2026 8:42 am
Here's Why Omeros (OMER) is a Great Momentum Stock to Buy
- Apr 27th, 2026 10:00 am
Wall Street Analysts Believe Omeros (OMER) Could Rally 222.76%: Here's is How to Trade
- Apr 27th, 2026 7:55 am
4 Medical Product Stocks to Buy From a Challenging Industry
- Apr 27th, 2026 6:27 am
Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer
- Apr 20th, 2026 5:00 am
CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA® (narsoplimab-wuug)
- Apr 16th, 2026 6:45 am
Does Omeros (OMER) Have the Potential to Rally 266.67% as Wall Street Analysts Expect?
- Apr 10th, 2026 7:55 am
Omeros Corporation Q4 2025 Earnings Call Summary
- Apr 1st, 2026 6:30 am
Omeros Corp (OMER) Q4 2025 Earnings Call Highlights: A Turnaround with Strategic Deals and FDA ...
- Mar 31st, 2026 9:02 pm
Omeros Q4 Earnings Call Highlights
- Mar 31st, 2026 4:06 pm
Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results
- Mar 31st, 2026 2:02 pm
Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026
- Mar 26th, 2026 6:45 am
Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment
- Mar 21st, 2026 1:23 am
Scroll